Genenta Science S.p.A. (GNTA) vs Quince Therapeutics (QNCX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Genenta Science S.p.A. (GNTA) has outperformed Quince Therapeutics (QNCX) over the past year, losing 78.4% versus a loss of 92.4%. Genenta Science S.p.A. is the larger company by market cap ($34.2 million vs $29.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNTA | QNCX |
|---|---|---|
| Share price | $0.7101 | $29.36 |
| Market cap | $34.24M | $29.86M |
| 1-day change | -5.95% | +9.88% |
| YTD return | -52.34% | -95.62% |
| 1-year return | -78.35% | -92.35% |
| 5-year return | — | -99.77% |
| EPS (TTM) | $-0.37 | $-214.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.00 | $910.00 |
| 52-week low | $0.55 | $15.10 |
| Distance from 52-week high | -92.90% | -96.77% |
| Average volume | 61.48K | 28.49K |
| Shares outstanding | 48.22M | 1.02M |
| Employees | 9 | — |
| Sector | Industrials | Health Care |
| Industry | Conglomerates | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GNTA has outperformed QNCX by 14.0 percentage points over the past year.
- The two companies sit in different sectors: Genenta Science S.p.A. in Industrials and Quince Therapeutics in Health Care.
About Genenta Science S.p.A.
GNTA stock →Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Industrials · Conglomerates · 9 employees
GNTA vs QNCX FAQ
Which is bigger, Genenta Science S.p.A. or Quince Therapeutics?
Genenta Science S.p.A. (GNTA) is larger, with a market capitalization of $34.24M compared with $29.86M for Quince Therapeutics (QNCX).
Which stock has performed better over the past year, GNTA or QNCX?
GNTA returned -78.35% over the past 12 months, compared with -92.35% for QNCX (price return, excluding dividends). Past performance does not predict future results.
Are Genenta Science S.p.A. and Quince Therapeutics in the same industry?
No. Genenta Science S.p.A. is in the Industrials sector, while Quince Therapeutics is in Health Care.